Venus Concept

Company Overview

Snapshot

Founded in February 2009 by Oded Ron-Edoute and Orit Ron-Edoute, Venus Concept operates with 201–500 employees. The company has raised a total of $113.05 million across 8 funding rounds from 8 investors. In November 2019, Venus Concept went public on NASDAQ.

Business overview

Venus Concept develops medical aesthetic devices, offering a broad portfolio of minimally invasive and noninvasive medical aesthetic technologies. The company's product lineup includes aesthetic device platforms such as Venus Versa and Venus Legacy, alongside hair restoration systems like NeoGraft and the. Serving over 60 countries and 29 direct markets, Venus Concept operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Aesthetic Devices.

Strategic signal

In May 2024, Venus Concept announced a $35 million Debt-to-Equity Exchange Transaction. This strategic financial maneuver indicates the company's efforts to optimize its capital structure and potentially reduce debt burden, signaling a focus on financial stability and long-term growth for investors.

Company Intelligence Q&A

What was a significant financial transaction for Venus Concept in May 2024?

In May 2024, Venus Concept announced a $35 million Debt-to-Equity Exchange Transaction.

When did Venus Concept go public?

Venus Concept went public on NASDAQ in November 2019.

What was a key product approval for Venus Concept in Australia?

In September 2024, Venus Concept announced Australian regulatory approval for its Venus Bliss MAX product.

What new product platform did Venus Concept launch in November 2023?

In November 2023, Venus Concept launched Venus Versa Pro, its new multi-application platform for face and body treatments.

What strategic branding initiative did Venus Concept undertake in October 2023?

In October 2023, Venus Concept launched new “Venus Aesthetic Intelligence” branding and an updated “Venus.ai” website to reflect a new company vision.